BCRX BioCryst Pharmaceuticals Inc

USD 7.42 0.28 3.921569
Icon

BioCryst Pharmaceuticals Inc (BCRX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 7.42

+0.28 (+3.92)%

USD 1.49B

2.09M

USD 14.75(+98.79%)

USD 18.00 (+142.59%)

Icon

BCRX

BioCryst Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 7.42
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.49B

USD 18.00 (+142.59%)

USD 7.42

BioCryst Pharmaceuticals Inc (BCRX) Stock Forecast

Show ratings and price targets of :
USD 14.75
(+98.79%)

Based on the BioCryst Pharmaceuticals Inc stock forecast from 3 analysts, the average analyst target price for BioCryst Pharmaceuticals Inc is USD 14.75 over the next 12 months. BioCryst Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of BioCryst Pharmaceuticals Inc is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, BioCryst Pharmaceuticals Inc’s stock price was USD 7.42. BioCryst Pharmaceuticals Inc’s stock price has changed by +3.34% over the past week, +15.58% over the past month and -0.67% over the last year.

No recent analyst target price found for BioCryst Pharmaceuticals Inc
No recent average analyst rating found for BioCryst Pharmaceuticals Inc

Company Overview BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPI...Read More

https://www.biocryst.com

4505 Emperor Boulevard, Durham, NC, United States, 27703

536

December

USD

USA

Adjusted Closing Price for BioCryst Pharmaceuticals Inc (BCRX)

Loading...

Unadjusted Closing Price for BioCryst Pharmaceuticals Inc (BCRX)

Loading...

Share Trading Volume for BioCryst Pharmaceuticals Inc Shares

Loading...

Compare Performance of BioCryst Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BCRX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To BioCryst Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +4.34 (+0.88%) USD126.85B 31.94 20.00

ETFs Containing BCRX

Symbol Name BCRX's Weight Expense Ratio Price(Change) Market Cap
BIGT:LSE
L&G Pharma Breakthrough U.. 2.93 % 0.49 % +8.40 (+1.06%) USD0.02B

Frequently Asked Questions About BioCryst Pharmaceuticals Inc (BCRX) Stock

Based on ratings from 3 analysts BioCryst Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 4 buy, sell and hold ratings.

Unfortunately we do not have enough data on BCRX's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for BCRX is USD 14.75 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 12.

Unfortunately we do not have enough data on BCRX's stock to indicate if its overvalued.

The last closing price of BCRX's stock was USD 7.42.

The most recent market capitalization for BCRX is USD 1.49B.

Based on targets from 3 analysts, the average taret price for BCRX is projected at USD 14.75 over the next 12 months. This means that BCRX's stock price may go up by +98.79% over the next 12 months.

Following are ETFs with the highest allocation to BioCryst Pharmaceuticals Inc's stock :

BIGT:LSE

As per our most recent records BioCryst Pharmaceuticals Inc has 536 Employees.

BioCryst Pharmaceuticals Inc's registered address is 4505 Emperor Boulevard, Durham, NC, United States, 27703. You can get more information about it from BioCryst Pharmaceuticals Inc's website at https://www.biocryst.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...